• +91 9169164321 (Asia)
  • +1(646)-781-7170 (Int'l)
  • help@24lifesciences.com
Cart (0)

COVID-19 Impact on Global Tardive Dyskinesia (TD) Treatment Drugs Market Size, Status and Forecast 2020-2026

report cover
  • 22 June 2020
  • Healthcare
  • 93 Pages
  • Report Code: 24LS-8622
  • Formate :   
Download FREE Report Sample Download PDF File

COVID 19 Impact Tardive Dyskinesia Treatment Drugs -MARKET ADVISORY SERVICES

This report focuses on the global Tardive Dyskinesia (TD) Treatment Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Tardive Dyskinesia (TD) Treatment Drugs development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study
Neurocrine Biosciences, Inc.
Teva Pharmaceutical Industries
Pfizer Inc.
Biogen
Novartis AG
AstraZeneca
GlaxoSmithKline plc.
Bayer AG
Sanofi

Market segment by Type, the product can be split into
Valbenazine
Deutetrabenazine
Market segment by Application, split into
Hospitals
Clinic
Others

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Tardive Dyskinesia (TD) Treatment Drugs status, future forecast, growth opportunity, key market and key players.
To present the Tardive Dyskinesia (TD) Treatment Drugs development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Tardive Dyskinesia (TD) Treatment Drugs are as follows:
History Year: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Tardive Dyskinesia (TD) Treatment Drugs Revenue
1.4 Market Analysis by Type
1.4.1 Global Tardive Dyskinesia (TD) Treatment Drugs Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Valbenazine
1.4.3 Deutetrabenazine
1.5 Market by Application
1.5.1 Global Tardive Dyskinesia (TD) Treatment Drugs Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Clinic
1.5.4 Others
1.6 Coronavirus Disease 2019 (Covid-19): Tardive Dyskinesia (TD) Treatment Drugs Industry Impact
1.6.1 How the Covid-19 is Affecting the Tardive Dyskinesia (TD) Treatment Drugs Industry
1.6.1.1 Tardive Dyskinesia (TD) Treatment Drugs Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Tardive Dyskinesia (TD) Treatment Drugs Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Tardive Dyskinesia (TD) Treatment Drugs Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 Global Growth Trends by Regions
2.1 Tardive Dyskinesia (TD) Treatment Drugs Market Perspective (2015-2026)
2.2 Tardive Dyskinesia (TD) Treatment Drugs Growth Trends by Regions
2.2.1 Tardive Dyskinesia (TD) Treatment Drugs Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Tardive Dyskinesia (TD) Treatment Drugs Historic Market Share by Regions (2015-2020)
2.2.3 Tardive Dyskinesia (TD) Treatment Drugs Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Tardive Dyskinesia (TD) Treatment Drugs Market Growth Strategy
2.3.6 Primary Interviews with Key Tardive Dyskinesia (TD) Treatment Drugs Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Tardive Dyskinesia (TD) Treatment Drugs Players by Market Size
3.1.1 Global Top Tardive Dyskinesia (TD) Treatment Drugs Players by Revenue (2015-2020)
3.1.2 Global Tardive Dyskinesia (TD) Treatment Drugs Revenue Market Share by Players (2015-2020)
3.1.3 Global Tardive Dyskinesia (TD) Treatment Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Tardive Dyskinesia (TD) Treatment Drugs Market Concentration Ratio
3.2.1 Global Tardive Dyskinesia (TD) Treatment Drugs Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Tardive Dyskinesia (TD) Treatment Drugs Revenue in 2019
3.3 Tardive Dyskinesia (TD) Treatment Drugs Key Players Head office and Area Served
3.4 Key Players Tardive Dyskinesia (TD) Treatment Drugs Product Solution and Service
3.5 Date of Enter into Tardive Dyskinesia (TD) Treatment Drugs Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)
4.1 Global Tardive Dyskinesia (TD) Treatment Drugs Historic Market Size by Type (2015-2020)
4.2 Global Tardive Dyskinesia (TD) Treatment Drugs Forecasted Market Size by Type (2021-2026)

5 Tardive Dyskinesia (TD) Treatment Drugs Breakdown Data by Application (2015-2026)
5.1 Global Tardive Dyskinesia (TD) Treatment Drugs Market Size by Application (2015-2020)
5.2 Global Tardive Dyskinesia (TD) Treatment Drugs Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Tardive Dyskinesia (TD) Treatment Drugs Market Size (2015-2020)
6.2 Tardive Dyskinesia (TD) Treatment Drugs Key Players in North America (2019-2020)
6.3 North America Tardive Dyskinesia (TD) Treatment Drugs Market Size by Type (2015-2020)
6.4 North America Tardive Dyskinesia (TD) Treatment Drugs Market Size by Application (2015-2020)

7 Europe
7.1 Europe Tardive Dyskinesia (TD) Treatment Drugs Market Size (2015-2020)
7.2 Tardive Dyskinesia (TD) Treatment Drugs Key Players in Europe (2019-2020)
7.3 Europe Tardive Dyskinesia (TD) Treatment Drugs Market Size by Type (2015-2020)
7.4 Europe Tardive Dyskinesia (TD) Treatment Drugs Market Size by Application (2015-2020)

8 China
8.1 China Tardive Dyskinesia (TD) Treatment Drugs Market Size (2015-2020)
8.2 Tardive Dyskinesia (TD) Treatment Drugs Key Players in China (2019-2020)
8.3 China Tardive Dyskinesia (TD) Treatment Drugs Market Size by Type (2015-2020)
8.4 China Tardive Dyskinesia (TD) Treatment Drugs Market Size by Application (2015-2020)

9 Japan
9.1 Japan Tardive Dyskinesia (TD) Treatment Drugs Market Size (2015-2020)
9.2 Tardive Dyskinesia (TD) Treatment Drugs Key Players in Japan (2019-2020)
9.3 Japan Tardive Dyskinesia (TD) Treatment Drugs Market Size by Type (2015-2020)
9.4 Japan Tardive Dyskinesia (TD) Treatment Drugs Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Tardive Dyskinesia (TD) Treatment Drugs Market Size (2015-2020)
10.2 Tardive Dyskinesia (TD) Treatment Drugs Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Tardive Dyskinesia (TD) Treatment Drugs Market Size by Type (2015-2020)
10.4 Southeast Asia Tardive Dyskinesia (TD) Treatment Drugs Market Size by Application (2015-2020)

11 India
11.1 India Tardive Dyskinesia (TD) Treatment Drugs Market Size (2015-2020)
11.2 Tardive Dyskinesia (TD) Treatment Drugs Key Players in India (2019-2020)
11.3 India Tardive Dyskinesia (TD) Treatment Drugs Market Size by Type (2015-2020)
11.4 India Tardive Dyskinesia (TD) Treatment Drugs Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Tardive Dyskinesia (TD) Treatment Drugs Market Size (2015-2020)
12.2 Tardive Dyskinesia (TD) Treatment Drugs Key Players in Central & South America (2019-2020)
12.3 Central & South America Tardive Dyskinesia (TD) Treatment Drugs Market Size by Type (2015-2020)
12.4 Central & South America Tardive Dyskinesia (TD) Treatment Drugs Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Neurocrine Biosciences, Inc.
13.1.1 Neurocrine Biosciences, Inc. Company Details
13.1.2 Neurocrine Biosciences, Inc. Business Overview and Its Total Revenue
13.1.3 Neurocrine Biosciences, Inc. Tardive Dyskinesia (TD) Treatment Drugs Introduction
13.1.4 Neurocrine Biosciences, Inc. Revenue in Tardive Dyskinesia (TD) Treatment Drugs Business (2015-2020))
13.1.5 Neurocrine Biosciences, Inc. Recent Development
13.2 Teva Pharmaceutical Industries
13.2.1 Teva Pharmaceutical Industries Company Details
13.2.2 Teva Pharmaceutical Industries Business Overview and Its Total Revenue
13.2.3 Teva Pharmaceutical Industries Tardive Dyskinesia (TD) Treatment Drugs Introduction
13.2.4 Teva Pharmaceutical Industries Revenue in Tardive Dyskinesia (TD) Treatment Drugs Business (2015-2020)
13.2.5 Teva Pharmaceutical Industries Recent Development
13.3 Pfizer Inc.
13.3.1 Pfizer Inc. Company Details
13.3.2 Pfizer Inc. Business Overview and Its Total Revenue
13.3.3 Pfizer Inc. Tardive Dyskinesia (TD) Treatment Drugs Introduction
13.3.4 Pfizer Inc. Revenue in Tardive Dyskinesia (TD) Treatment Drugs Business (2015-2020)
13.3.5 Pfizer Inc. Recent Development
13.4 Biogen
13.4.1 Biogen Company Details
13.4.2 Biogen Business Overview and Its Total Revenue
13.4.3 Biogen Tardive Dyskinesia (TD) Treatment Drugs Introduction
13.4.4 Biogen Revenue in Tardive Dyskinesia (TD) Treatment Drugs Business (2015-2020)
13.4.5 Biogen Recent Development
13.5 Novartis AG
13.5.1 Novartis AG Company Details
13.5.2 Novartis AG Business Overview and Its Total Revenue
13.5.3 Novartis AG Tardive Dyskinesia (TD) Treatment Drugs Introduction
13.5.4 Novartis AG Revenue in Tardive Dyskinesia (TD) Treatment Drugs Business (2015-2020)
13.5.5 Novartis AG Recent Development
13.6 AstraZeneca
13.6.1 AstraZeneca Company Details
13.6.2 AstraZeneca Business Overview and Its Total Revenue
13.6.3 AstraZeneca Tardive Dyskinesia (TD) Treatment Drugs Introduction
13.6.4 AstraZeneca Revenue in Tardive Dyskinesia (TD) Treatment Drugs Business (2015-2020)
13.6.5 AstraZeneca Recent Development
13.7 GlaxoSmithKline plc.
13.7.1 GlaxoSmithKline plc. Company Details
13.7.2 GlaxoSmithKline plc. Business Overview and Its Total Revenue
13.7.3 GlaxoSmithKline plc. Tardive Dyskinesia (TD) Treatment Drugs Introduction
13.7.4 GlaxoSmithKline plc. Revenue in Tardive Dyskinesia (TD) Treatment Drugs Business (2015-2020)
13.7.5 GlaxoSmithKline plc. Recent Development
13.8 Bayer AG
13.8.1 Bayer AG Company Details
13.8.2 Bayer AG Business Overview and Its Total Revenue
13.8.3 Bayer AG Tardive Dyskinesia (TD) Treatment Drugs Introduction
13.8.4 Bayer AG Revenue in Tardive Dyskinesia (TD) Treatment Drugs Business (2015-2020)
13.8.5 Bayer AG Recent Development
13.9 Sanofi
13.9.1 Sanofi Company Details
13.9.2 Sanofi Business Overview and Its Total Revenue
13.9.3 Sanofi Tardive Dyskinesia (TD) Treatment Drugs Introduction
13.9.4 Sanofi Revenue in Tardive Dyskinesia (TD) Treatment Drugs Business (2015-2020)
13.9.5 Sanofi Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
List of Tables

Table 1. Tardive Dyskinesia (TD) Treatment Drugs Key Market Segments

Table 2. Key Players Covered: Ranking by Tardive Dyskinesia (TD) Treatment Drugs Revenue

Table 3. Ranking of Global Top Tardive Dyskinesia (TD) Treatment Drugs Manufacturers by Revenue (US$ Million) in 2019

Table 4. Global Tardive Dyskinesia (TD) Treatment Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2026

Table 5. Key Players of Valbenazine

Table 6. Key Players of Deutetrabenazine

Table 7. COVID-19 Impact Global Market: (Four Tardive Dyskinesia (TD) Treatment Drugs Market Size Forecast Scenarios)

Table 8. Opportunities and Trends for Tardive Dyskinesia (TD) Treatment Drugs Players in the COVID-19 Landscape

Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis

Table 10. Key Regions/Countries Measures against Covid-19 Impact

Table 11. Proposal for Tardive Dyskinesia (TD) Treatment Drugs Players to Combat Covid-19 Impact

Table 12. Global Tardive Dyskinesia (TD) Treatment Drugs Market Size Growth by Application (US$ Million): 2020 VS 2026

Table 13. Global Tardive Dyskinesia (TD) Treatment Drugs Market Size by Regions (US$ Million): 2020 VS 2026

Table 14. Global Tardive Dyskinesia (TD) Treatment Drugs Market Size by Regions (2015-2020) (US$ Million)

Table 15. Global Tardive Dyskinesia (TD) Treatment Drugs Market Share by Regions (2015-2020)

Table 16. Global Tardive Dyskinesia (TD) Treatment Drugs Forecasted Market Size by Regions (2021-2026) (US$ Million)

Table 17. Global Tardive Dyskinesia (TD) Treatment Drugs Market Share by Regions (2021-2026)

Table 18. Market Top Trends

Table 19. Key Drivers: Impact Analysis

Table 20. Key Challenges

Table 21. Tardive Dyskinesia (TD) Treatment Drugs Market Growth Strategy

Table 22. Main Points Interviewed from Key Tardive Dyskinesia (TD) Treatment Drugs Players

Table 23. Global Tardive Dyskinesia (TD) Treatment Drugs Revenue by Players (2015-2020) (Million US$)

Table 24. Global Tardive Dyskinesia (TD) Treatment Drugs Market Share by Players (2015-2020)

Table 25. Global Top Tardive Dyskinesia (TD) Treatment Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Tardive Dyskinesia (TD) Treatment Drugs as of 2019)

Table 26. Global Tardive Dyskinesia (TD) Treatment Drugs by Players Market Concentration Ratio (CR5 and HHI)

Table 27. Key Players Headquarters and Area Served

Table 28. Key Players Tardive Dyskinesia (TD) Treatment Drugs Product Solution and Service

Table 29. Date of Enter into Tardive Dyskinesia (TD) Treatment Drugs Market

Table 30. Mergers & Acquisitions, Expansion Plans

Table 31. Global Tardive Dyskinesia (TD) Treatment Drugs Market Size by Type (2015-2020) (Million US$)

Table 32. Global Tardive Dyskinesia (TD) Treatment Drugs Market Size Share by Type (2015-2020)

Table 33. Global Tardive Dyskinesia (TD) Treatment Drugs Revenue Market Share by Type (2021-2026)

Table 34. Global Tardive Dyskinesia (TD) Treatment Drugs Market Size Share by Application (2015-2020)

Table 35. Global Tardive Dyskinesia (TD) Treatment Drugs Market Size by Application (2015-2020) (Million US$)

Table 36. Global Tardive Dyskinesia (TD) Treatment Drugs Market Size Share by Application (2021-2026)

Table 37. North America Key Players Tardive Dyskinesia (TD) Treatment Drugs Revenue (2019-2020) (Million US$)

Table 38. North America Key Players Tardive Dyskinesia (TD) Treatment Drugs Market Share (2019-2020)

Table 39. North America Tardive Dyskinesia (TD) Treatment Drugs Market Size by Type (2015-2020) (Million US$)

Table 40. North America Tardive Dyskinesia (TD) Treatment Drugs Market Share by Type (2015-2020)

Table 41. North America Tardive Dyskinesia (TD) Treatment Drugs Market Size by Application (2015-2020) (Million US$)

Table 42. North America Tardive Dyskinesia (TD) Treatment Drugs Market Share by Application (2015-2020)

Table 43. Europe Key Players Tardive Dyskinesia (TD) Treatment Drugs Revenue (2019-2020) (Million US$)

Table 44. Europe Key Players Tardive Dyskinesia (TD) Treatment Drugs Market Share (2019-2020)

Table 45. Europe Tardive Dyskinesia (TD) Treatment Drugs Market Size by Type (2015-2020) (Million US$)

Table 46. Europe Tardive Dyskinesia (TD) Treatment Drugs Market Share by Type (2015-2020)

Table 47. Europe Tardive Dyskinesia (TD) Treatment Drugs Market Size by Application (2015-2020) (Million US$)

Table 48. Europe Tardive Dyskinesia (TD) Treatment Drugs Market Share by Application (2015-2020)

Table 49. China Key Players Tardive Dyskinesia (TD) Treatment Drugs Revenue (2019-2020) (Million US$)

Table 50. China Key Players Tardive Dyskinesia (TD) Treatment Drugs Market Share (2019-2020)

Table 51. China Tardive Dyskinesia (TD) Treatment Drugs Market Size by Type (2015-2020) (Million US$)

Table 52. China Tardive Dyskinesia (TD) Treatment Drugs Market Share by Type (2015-2020)

Table 53. China Tardive Dyskinesia (TD) Treatment Drugs Market Size by Application (2015-2020) (Million US$)

Table 54. China Tardive Dyskinesia (TD) Treatment Drugs Market Share by Application (2015-2020)

Table 55. Japan Key Players Tardive Dyskinesia (TD) Treatment Drugs Revenue (2019-2020) (Million US$)

Table 56. Japan Key Players Tardive Dyskinesia (TD) Treatment Drugs Market Share (2019-2020)

Table 57. Japan Tardive Dyskinesia (TD) Treatment Drugs Market Size by Type (2015-2020) (Million US$)

Table 58. Japan Tardive Dyskinesia (TD) Treatment Drugs Market Share by Type (2015-2020)

Table 59. Japan Tardive Dyskinesia (TD) Treatment Drugs Market Size by Application (2015-2020) (Million US$)

Table 60. Japan Tardive Dyskinesia (TD) Treatment Drugs Market Share by Application (2015-2020)

Table 61. Southeast Asia Key Players Tardive Dyskinesia (TD) Treatment Drugs Revenue (2019-2020) (Million US$)

Table 62. Southeast Asia Key Players Tardive Dyskinesia (TD) Treatment Drugs Market Share (2019-2020)

Table 63. Southeast Asia Tardive Dyskinesia (TD) Treatment Drugs Market Size by Type (2015-2020) (Million US$)

Table 64. Southeast Asia Tardive Dyskinesia (TD) Treatment Drugs Market Share by Type (2015-2020)

Table 65. Southeast Asia Tardive Dyskinesia (TD) Treatment Drugs Market Size by Application (2015-2020) (Million US$)

Table 66. Southeast Asia Tardive Dyskinesia (TD) Treatment Drugs Market Share by Application (2015-2020)

Table 67. India Key Players Tardive Dyskinesia (TD) Treatment Drugs Revenue (2019-2020) (Million US$)

Table 68. India Key Players Tardive Dyskinesia (TD) Treatment Drugs Market Share (2019-2020)

Table 69. India Tardive Dyskinesia (TD) Treatment Drugs Market Size by Type (2015-2020) (Million US$)

Table 70. India Tardive Dyskinesia (TD) Treatment Drugs Market Share by Type (2015-2020)

Table 71. India Tardive Dyskinesia (TD) Treatment Drugs Market Size by Application (2015-2020) (Million US$)

Table 72. India Tardive Dyskinesia (TD) Treatment Drugs Market Share by Application (2015-2020)

Table 73. Central & South America Key Players Tardive Dyskinesia (TD) Treatment Drugs Revenue (2019-2020) (Million US$)

Table 74. Central & South America Key Players Tardive Dyskinesia (TD) Treatment Drugs Market Share (2019-2020)

Table 75. Central & South America Tardive Dyskinesia (TD) Treatment Drugs Market Size by Type (2015-2020) (Million US$)

Table 76. Central & South America Tardive Dyskinesia (TD) Treatment Drugs Market Share by Type (2015-2020)

Table 77. Central & South America Tardive Dyskinesia (TD) Treatment Drugs Market Size by Application (2015-2020) (Million US$)

Table 78. Central & South America Tardive Dyskinesia (TD) Treatment Drugs Market Share by Application (2015-2020)

Table 79. Neurocrine Biosciences, Inc. Company Details

Table 80. Neurocrine Biosciences, Inc. Business Overview

Table 81. Neurocrine Biosciences, Inc. Product

Table 82. Neurocrine Biosciences, Inc. Revenue in Tardive Dyskinesia (TD) Treatment Drugs Business (2015-2020) (Million US$)

Table 83. Neurocrine Biosciences, Inc. Recent Development

Table 84. Teva Pharmaceutical Industries Company Details

Table 85. Teva Pharmaceutical Industries Business Overview

Table 86. Teva Pharmaceutical Industries Product

Table 87. Teva Pharmaceutical Industries Revenue in Tardive Dyskinesia (TD) Treatment Drugs Business (2015-2020) (Million US$)

Table 88. Teva Pharmaceutical Industries Recent Development

Table 89. Pfizer Inc. Company Details

Table 90. Pfizer Inc. Business Overview

Table 91. Pfizer Inc. Product

Table 92. Pfizer Inc. Revenue in Tardive Dyskinesia (TD) Treatment Drugs Business (2015-2020) (Million US$)

Table 93. Pfizer Inc. Recent Development

Table 94. Biogen Company Details

Table 95. Biogen Business Overview

Table 96. Biogen Product

Table 97. Biogen Revenue in Tardive Dyskinesia (TD) Treatment Drugs Business (2015-2020) (Million US$)

Table 98. Biogen Recent Development

Table 99. Novartis AG Company Details

Table 100. Novartis AG Business Overview

Table 101. Novartis AG Product

Table 102. Novartis AG Revenue in Tardive Dyskinesia (TD) Treatment Drugs Business (2015-2020) (Million US$)

Table 103. Novartis AG Recent Development

Table 104. AstraZeneca Company Details

Table 105. AstraZeneca Business Overview

Table 106. AstraZeneca Product

Table 107. AstraZeneca Revenue in Tardive Dyskinesia (TD) Treatment Drugs Business (2015-2020) (Million US$)

Table 108. AstraZeneca Recent Development

Table 109. GlaxoSmithKline plc. Company Details

Table 110. GlaxoSmithKline plc. Business Overview

Table 111. GlaxoSmithKline plc. Product

Table 112. GlaxoSmithKline plc. Revenue in Tardive Dyskinesia (TD) Treatment Drugs Business (2015-2020) (Million US$)

Table 113. GlaxoSmithKline plc. Recent Development

Table 114. Bayer AG Business Overview

Table 115. Bayer AG Product

Table 116. Bayer AG Company Details

Table 117. Bayer AG Revenue in Tardive Dyskinesia (TD) Treatment Drugs Business (2015-2020) (Million US$)

Table 118. Bayer AG Recent Development

Table 119. Sanofi Company Details

Table 120. Sanofi Business Overview

Table 121. Sanofi Product

Table 122. Sanofi Revenue in Tardive Dyskinesia (TD) Treatment Drugs Business (2015-2020) (Million US$)

Table 123. Sanofi Recent Development

Table 124. Research Programs/Design for This Report

Table 125. Key Data Information from Secondary Sources

Table 126. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Tardive Dyskinesia (TD) Treatment Drugs Market Share by Type: 2020 VS 2026

Figure 2. Valbenazine Features

Figure 3. Deutetrabenazine Features

Figure 4. Global Tardive Dyskinesia (TD) Treatment Drugs Market Share by Application: 2020 VS 2026

Figure 5. Hospitals Case Studies

Figure 6. Clinic Case Studies

Figure 7. Others Case Studies

Figure 8. Tardive Dyskinesia (TD) Treatment Drugs Report Years Considered

Figure 9. Global Tardive Dyskinesia (TD) Treatment Drugs Market Size YoY Growth 2015-2026 (US$ Million)

Figure 10. Global Tardive Dyskinesia (TD) Treatment Drugs Market Share by Regions: 2020 VS 2026

Figure 11. Global Tardive Dyskinesia (TD) Treatment Drugs Market Share by Regions (2021-2026)

Figure 12. Porter's Five Forces Analysis

Figure 13. Global Tardive Dyskinesia (TD) Treatment Drugs Market Share by Players in 2019

Figure 14. Global Top Tardive Dyskinesia (TD) Treatment Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Tardive Dyskinesia (TD) Treatment Drugs as of 2019

Figure 15. The Top 10 and 5 Players Market Share by Tardive Dyskinesia (TD) Treatment Drugs Revenue in 2019

Figure 16. North America Tardive Dyskinesia (TD) Treatment Drugs Market Size YoY Growth (2015-2020) (Million US$)

Figure 17. Europe Tardive Dyskinesia (TD) Treatment Drugs Market Size YoY Growth (2015-2020) (Million US$)

Figure 18. China Tardive Dyskinesia (TD) Treatment Drugs Market Size YoY Growth (2015-2020) (Million US$)

Figure 19. Japan Tardive Dyskinesia (TD) Treatment Drugs Market Size YoY Growth (2015-2020) (Million US$)

Figure 20. Southeast Asia Tardive Dyskinesia (TD) Treatment Drugs Market Size YoY Growth (2015-2020) (Million US$)

Figure 21. India Tardive Dyskinesia (TD) Treatment Drugs Market Size YoY Growth (2015-2020) (Million US$)

Figure 22. Central & South America Tardive Dyskinesia (TD) Treatment Drugs Market Size YoY Growth (2015-2020) (Million US$)

Figure 23. Neurocrine Biosciences, Inc. Total Revenue (US$ Million): 2019 Compared with 2018

Figure 24. Neurocrine Biosciences, Inc. Revenue Growth Rate in Tardive Dyskinesia (TD) Treatment Drugs Business (2015-2020)

Figure 25. Teva Pharmaceutical Industries Total Revenue (US$ Million): 2019 Compared with 2018

Figure 26. Teva Pharmaceutical Industries Revenue Growth Rate in Tardive Dyskinesia (TD) Treatment Drugs Business (2015-2020)

Figure 27. Pfizer Inc. Total Revenue (US$ Million): 2019 Compared with 2018

Figure 28. Pfizer Inc. Revenue Growth Rate in Tardive Dyskinesia (TD) Treatment Drugs Business (2015-2020)

Figure 29. Biogen Total Revenue (US$ Million): 2019 Compared with 2018

Figure 30. Biogen Revenue Growth Rate in Tardive Dyskinesia (TD) Treatment Drugs Business (2015-2020)

Figure 31. Novartis AG Total Revenue (US$ Million): 2019 Compared with 2018

Figure 32. Novartis AG Revenue Growth Rate in Tardive Dyskinesia (TD) Treatment Drugs Business (2015-2020)

Figure 33. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018

Figure 34. AstraZeneca Revenue Growth Rate in Tardive Dyskinesia (TD) Treatment Drugs Business (2015-2020)

Figure 35. GlaxoSmithKline plc. Total Revenue (US$ Million): 2019 Compared with 2018

Figure 36. GlaxoSmithKline plc. Revenue Growth Rate in Tardive Dyskinesia (TD) Treatment Drugs Business (2015-2020)

Figure 37. Bayer AG Total Revenue (US$ Million): 2019 Compared with 2018

Figure 38. Bayer AG Revenue Growth Rate in Tardive Dyskinesia (TD) Treatment Drugs Business (2015-2020)

Figure 39. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018

Figure 40. Sanofi Revenue Growth Rate in Tardive Dyskinesia (TD) Treatment Drugs Business (2015-2020)

Figure 41. Bottom-up and Top-down Approaches for This Report

Figure 42. Data Triangulation

Figure 43. Key Executives Interviewed

Neurocrine Biosciences, Inc.

Teva Pharmaceutical Industries

Pfizer Inc.

Biogen

Novartis AG

AstraZeneca

GlaxoSmithKline plc.

Bayer AG

Sanofi

CHOOSE YOUR BUYING OPTION COVID-19 Revised Pricing Of the Month

SECURITY ASSUREDpayment image

Frequently Asked Questions ?

  • A license granted to one user.

    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License

    A license granted to multiple users.

  • Site License

    A license granted to a single business site/establishment.

  • Corporate License, Global License

    A license granted to all employees within organisation access to the product.

  • Upto Working 24 to 48 hrs

  • Upto 72 hrs max - Weekends and Public Holidays

  • Online Payments with PayPal and CCavenue

  • Wire Transfer/Bank Transfer

  • Email

  • Hard Copy

CHECK TODAYS BEST PRICE

BEST PRICE: $3159

SOME OF OUR CLIENTS

OUR KEY POINTS

  • Comprehensive Research

    Offers Penetrative insights & holistic understanding of the market

  • Data Accuracy & Reliability

    Strictly follows the Research Meth-odology for flawless results

  • Competitive Pricing

    Ensure the best and affordable pricing

  • Security & Confidentiality

    All your transactions are secured end-to-end, ensuring a satisfactory purchase